NANOBIOTIX SA - ADR (NBTX:NASDAQ)
$30.34 -0.25 (-0.8173%)
Analysed NANOBIOTIX SA - ADR (NBTX:NASDAQ) News Sources
Voting Rights and Shares Capital of the Company
07-04-2026
yahoo.com
Nanobiotix H2 Earnings Call Highlights
01-04-2026
marketbeat.com
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
31-03-2026
yahoo.com
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
30-03-2026
yahoo.com
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026
26-03-2026
yahoo.com
Sector Update: Health Care Stocks Gain Late Afternoon
25-03-2026
yahoo.com
NANOBIOTIX Statement Regarding Recent Media Speculation
25-03-2026
yahoo.com
NANOBIOTIX to Participate in Investor Conferences in March
25-02-2026
yahoo.com
NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
15-12-2025
yahoo.com
Nanobiotix (ENXTPA:NANO): Assessing Valuation After a Powerful Multi‑Month Share Price Surge
08-12-2025
yahoo.com
What is the current price of NANOBIOTIX SA - ADR (NBTX:NASDAQ)?
The current price of NANOBIOTIX SA - ADR (NBTX:NASDAQ) is $30.34.
NANOBIOTIX SA - ADR (NBTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of NANOBIOTIX SA - ADR (NBTX:NASDAQ) since the previous trading day is $-0.25.
NANOBIOTIX SA - ADR (NBTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of NANOBIOTIX SA - ADR (NBTX:NASDAQ) since the previous trading day is -0.8173%.
What is the most recent average sentiment score for NANOBIOTIX SA - ADR (NBTX:NASDAQ)?
The most recent average sentiment score for NANOBIOTIX SA - ADR (NBTX:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for NANOBIOTIX SA - ADR (NBTX:NASDAQ)?
The most recent sentiment for NANOBIOTIX SA - ADR (NBTX:NASDAQ) is .
SEC-8K** Filing Available For NANOBIOTIX SA - ADR (NBTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.